Medical Properties Trust (MPW) Downgraded by Robert W. Baird

Medical Properties Trust (NYSE:MPW) was downgraded by stock analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, Marketbeat reports. They presently have a $13.00 target price on the real estate investment trust’s stock, down from their prior target price of $15.00. Robert W. Baird’s price objective suggests a potential downside of 2.11% from the company’s current price.

MPW has been the topic of several other research reports. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 price objective for the company in a research report on Tuesday, October 24th. ValuEngine raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. SunTrust Banks reissued a “buy” rating and issued a $15.00 price objective on shares of Medical Properties Trust in a research report on Friday, November 3rd. JPMorgan Chase & Co. raised shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price objective for the company in a research report on Friday, December 15th. Finally, KeyCorp reissued a “hold” rating on shares of Medical Properties Trust in a research report on Sunday, September 17th. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. Medical Properties Trust currently has an average rating of “Hold” and a consensus target price of $14.45.

Shares of Medical Properties Trust (NYSE:MPW) traded down $0.27 during trading hours on Friday, hitting $13.28. 3,511,582 shares of the stock traded hands, compared to its average volume of 2,050,000. The stock has a market capitalization of $4,840.00, a P/E ratio of 17.47, a price-to-earnings-growth ratio of 1.67 and a beta of 0.96. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 1.26. Medical Properties Trust has a 1-year low of $11.90 and a 1-year high of $14.22.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.01. The firm had revenue of $176.60 million for the quarter, compared to the consensus estimate of $172.57 million. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The firm’s revenue was up 39.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.30 earnings per share. sell-side analysts forecast that Medical Properties Trust will post 1.33 earnings per share for the current fiscal year.

Hedge funds have recently made changes to their positions in the company. BlueCrest Capital Management Ltd bought a new position in Medical Properties Trust during the 2nd quarter valued at $5,349,000. Systematic Financial Management LP bought a new position in Medical Properties Trust during the 2nd quarter valued at $29,018,000. Brown Advisory Inc. boosted its stake in Medical Properties Trust by 22.0% during the 3rd quarter. Brown Advisory Inc. now owns 49,784 shares of the real estate investment trust’s stock valued at $653,000 after acquiring an additional 8,968 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Medical Properties Trust by 26.5% during the 2nd quarter. Goldman Sachs Group Inc. now owns 2,091,500 shares of the real estate investment trust’s stock valued at $26,917,000 after acquiring an additional 438,140 shares during the last quarter. Finally, Shelton Capital Management boosted its stake in Medical Properties Trust by 69.9% during the 2nd quarter. Shelton Capital Management now owns 27,660 shares of the real estate investment trust’s stock valued at $356,000 after acquiring an additional 11,382 shares during the last quarter. Institutional investors and hedge funds own 81.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was published by American Market News and is the property of of American Market News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/06/medical-properties-trust-mpw-downgraded-by-robert-w-baird.html.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.